# Hydroxyethyl Starch and Renal Function After Hip Replacement Surgery

> **NCT01486576** · PHASE4 · COMPLETED · sponsor: **Regional Hospital Holstebro** · enrollment: 42 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Voluven (Hydroxyethyl starch 130/0,4)
- **DRUG:** Sodium Chloride 9 mg/ml

## Key facts

- **NCT ID:** NCT01486576
- **Lead sponsor:** Regional Hospital Holstebro
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2013-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01486576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01486576, "Hydroxyethyl Starch and Renal Function After Hip Replacement Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01486576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*